Related Experiment Video
Updated: Aug 20, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 25, 2014
Hepatitis C virus infection in Japan
1Japanese Red Cross Central Blood Center, Tokyo.
Insights
Hepatitis C virus (HCV) antibody screening began in 1989 due to its link to liver cancer. Millions in Japan are infected, primarily through past blood transfusions and horizontal transmission.
Area of Science:
- Hepatology and Virology
- Infectious Disease Epidemiology
- Public Health
Background:
- High incidence of non-A, non-B post-transfusion hepatitis.
- Established association between hepatitis C virus (HCV) infection and hepatocellular carcinoma (liver cancer).
Purpose of the Study:
- To report on the implementation of HCV antibody screening for blood transfusions.
- To assess the seroepidemiological landscape of HCV infection in Japan.
Main Methods:
- Initiation of HCV antibody screening for all blood donations starting November 1989.
- Conducting seroepidemiological studies to determine the prevalence of HCV infection.
Main Results:
- Significant prevalence of HCV infection identified across various liver conditions: acute hepatitis, chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.
- Approximately 1.6 million individuals in Japan are currently HCV antibody-positive.
- Identified major transmission routes including past horizontal blood-borne infections and blood transfusions.
Conclusions:
- HCV poses a substantial public health challenge in Japan, with millions infected.
- Blood transfusion and historical blood-borne transmission are key routes for HCV infection.
- Ongoing surveillance and screening are crucial for managing HCV prevalence and preventing liver disease.
Abstract:
Because of the high incidence of non-A non-B post transfusion hepatitis and its relation to hepatocellular carcinoma, HCV antibody screening for blood transfusion was begun in November 1989. Seroepidemiological studies revealed the great magnitude of HCV infection in acute hepatitis, chronic hepatitis, liver cirrhosis and hepatocellular carcinoma in Japan. Approximately 1.6 million HCV antibody-positive persons are now in Japan. Major routes of infection are considered to be horizontal blood borne infection in the past and blood transfusion.
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Yellow Fever
Cytomegalovirus Disease
Hepatitis
Viral Hepatitis I: Introduction

